58 related articles for article (PubMed ID: 36408336)
1. The Prognostic Nutritional Index in patients with microsatellite instability-high metastatic gastric or gastroesophageal cancers receiving immune checkpoint inhibitors.
Ghelardi F; Fucà G; Cavalli C; Shitara K; Cohen R; Ambrosini M; Maron SB; Cerantola R; Nasca V; Liberti GD; Zambelli L; Palazzo M; Salati M; Aoki Y; Kawazoe A; Cowzer D; Lonardi S; André T; Randon G; Pietrantonio F
Dig Liver Dis; 2024 May; ():. PubMed ID: 38772790
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of perioperative changes in the prognostic nutritional index in patients with surgically resected non-small cell lung cancer.
Hayasaka K; Notsuda H; Onodera K; Watanabe T; Watanabe Y; Suzuki T; Hirama T; Oishi H; Niikawa H; Okada Y
Surg Today; 2024 May; ():. PubMed ID: 38700587
[TBL] [Abstract][Full Text] [Related]
3. Survival Impact of Inflammation-based Prognostic Scores in Metastatic or Unresectable Esophageal Cancer Treated With Pembrolizumab Plus Chemotherapy.
Sugase T; Kanemura T; Takeoka T; Matsuura N; Masuike Y; Shinno N; Hara H; Kitakaze M; Kubo M; Mukai Y; Sueda T; Hasegawa S; Akita H; Nishimura J; Wada H; Yasui M; Omori T; Miyata H
J Immunother; 2024 Jun; ():. PubMed ID: 38828771
[TBL] [Abstract][Full Text] [Related]
4. Analyzing HALP and PNI scores as prognostic factors in metastatic head and neck cancers.
Duzkopru Y; Kocanoglu A; Yigitbay M; Dogan O; Sahinli H; Yazilitas D
Asian J Surg; 2024 May; ():. PubMed ID: 38704268
[TBL] [Abstract][Full Text] [Related]
5. The Hammersmith Score Optimises Patient Selection and Predicts for Overall Survival in Early-Phase Cancer Trial Participants Independent of Tumour Burden.
Korolewicz JA; Scheiner B; Fulgenzi CAM; D'Alessio A; Cortellini A; Pascual C; Mehan A; Partridge S; Gujral DM; Mohammed W; Mohammed O; Grzesiak A; Booker L; Cleator S; Pokrovska T; Saleem W; Rackie J; Needham Y; Krell J; McNeish I; Tookman L; Park WE; Asif M; Evans JS; Pinato DJ
Chemotherapy; 2024 Apr; ():1-7. PubMed ID: 38679017
[TBL] [Abstract][Full Text] [Related]
6. Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors.
Ancel J; Dormoy V; Raby BN; Dalstein V; Durlach A; Dewolf M; Gilles C; Polette M; Deslée G
Front Immunol; 2023; 14():1171649. PubMed ID: 37283751
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xia H; Zhang W; Zheng Q; Zhang Y; Mu X; Wei C; Wang X; Liu Y
Heliyon; 2023 Aug; 9(8):e17400. PubMed ID: 37520982
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Pretreatment Prognostic Nutritional Index in Advanced Lung Cancer Patients Receiving First-Line Immunotherapy: A Meta-Analysis.
Yang J; Li H; Li L; Lv J
Cureus; 2024 Jan; 16(1):e52720. PubMed ID: 38384634
[TBL] [Abstract][Full Text] [Related]
9. Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor.
Fang Q; Yu J; Luo J; Deng Q; Chen B; He Y; Zhang J; Zhou C
Clin Med Insights Oncol; 2022; 16():11795549221137134. PubMed ID: 36408336
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of prognostic nutritional index and its variations in advanced non-small-cell lung cancer patients treated with anlotinib monotherapy.
Chen T; Liang G; Xiang Z; He J; Xu X; Tang M
J Clin Lab Anal; 2022 Apr; 36(4):e24300. PubMed ID: 35179795
[TBL] [Abstract][Full Text] [Related]
11. Impact of prognostic nutritional index change on prognosis after colorectal cancer surgery under propofol or sevoflurane anesthesia.
Zhang L; Liu C; Yan Q; Cai X
BMC Anesthesiol; 2024 Jan; 24(1):12. PubMed ID: 38172695
[TBL] [Abstract][Full Text] [Related]
12. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.
Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M
Front Oncol; 2023; 13():1041140. PubMed ID: 37007079
[TBL] [Abstract][Full Text] [Related]
13. Oncologic impact of preoperative prognostic nutritional index change in resected pancreatic cancer following neoadjuvant chemotherapy.
Kim KH; Hwang HK; Kang IC; Lee WJ; Kang CM
Pancreatology; 2020 Mar; 20(2):247-253. PubMed ID: 31889624
[TBL] [Abstract][Full Text] [Related]
14. Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy.
Fan R; Chen Y; Xu G; Pan W; Lv Y; Zhang Z
Front Oncol; 2023; 13():996312. PubMed ID: 37077828
[TBL] [Abstract][Full Text] [Related]
15. The impact of immune checkpoint inhibitors on cost and quality of life in the initial treatment of patients with advanced or metastatic NSCLC.
Procailo K
Am J Manag Care; 2021 Oct; 27(18 Suppl):S333-S339. PubMed ID: 34668681
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
